'Game-changing' immunotherapy doubles head and neck cancer survival

(Institute of Cancer Research) An immunotherapy drug has been hailed as a potential 'game changer' after being found to greatly improve survival for patients with relapsed head and neck cancer -- a disease which is notoriously difficult to treat.